Global Clinical Chemistry Enzymes Market is forecasted to reach a substantial US$ 5.7 Billion by 2033, according to Future Market Insights

Clinical Chemistry Enzymes Market Clinical Chemistry Enzymes Market

According to study by Future Market Insights, the global clinical chemistry enzymes market growth is anticipated to expand at a CAGR of 5.9% over the forecasted time period. The market value is expected to have grown from US$ 3.2 billion in 2023 to US$ 5.7 billion by 2033. At the end of 2022, the market for clinical chemistry enzymes was valued at US$ 3.1 billion, and in 2023, it is expected to rise by 5.3% year over year.

The clinical chemistry enzymes market plays a vital role in the field of clinical diagnostics, facilitating the measurement of various analytes for disease diagnosis, monitoring, and research purposes.

The rising global burden of chronic diseases such as diabetes, cardiovascular diseases, and cancer has led to an increased demand for clinical chemistry testing. Enzymes are crucial components in diagnostic assays for measuring biomarkers associated with these diseases, contributing to market growth.

Request a Sample copy of this Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-17807

The shift toward personalized medicine has increased the need for precise and reliable diagnostic tests. Clinical chemistry enzymes play a crucial role in measuring specific biomarkers for personalized treatment decisions. The demand for personalized medicine and targeted therapies has contributed to the growth of the clinical chemistry enzymes market.

Key players in the clinical chemistry enzymes market often engage in strategic collaborations, partnerships, and acquisitions to enhance their product portfolios, expand their market presence, and develop innovative enzyme solutions. These collaborations contribute to the overall market growth.

Key Takeaways:

  • By enzyme type, acid phosphatase – ACP accounts for US$ 411.8 million in 2022. Acid phosphatase is commonly used as a biomarker to assess prostate health.
  • By application, diagnostics purpose accounts for US$ 2.0 Billion in 2022. Clinical chemistry enzymes are essential biomarkers used for the early detection and diagnosis of various diseases and medical conditions
  • Hospitals held more than 35.6% of the global market share in 2022. Hospitals handle a large volume of patients for diagnostic testing on a daily basis
  • By region, North America held dominant share in world in 2022. The increasing frequency of various liver illnesses will drive market expansion in North America.

Reach Out To Our Analyst And Get All Your Queries Answered! https://www.futuremarketinsights.com/ask-question/rep-gb-17807

Market Competition:

The clinical chemistry enzymes market is highly competitive, with key players including Thermo Fisher Scientific. These companies are constantly participating conferences, award competition with their products and launching new products to gain a larger market share, with a focus on affordability, convenience, and effectiveness.

  • In September 2021, Thermo Fisher Scientific has announced the availability of their fully automated analyzers, which are intended primarily for applications involving enzyme assays.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the clinical chemistry enzymes market in its latest study, presenting a historical demand assessment of 2017 – 2022 and projections for 2023 – 2033. The global clinical chemistry enzymes market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader

Key Companies Profiled:

  1. Takara Bio, Inc.
  2. Promega Corporation
  3. Enzo Life Sciences, Inc.
  4. Merck KGaA
  5. Thermo Fisher Scientific, Inc.
  6. Creative Enzyme
  7. F. Hoffmann-La Roche Ltd.
  8. Solis BioDyne.
  9. Ambliqon A/S.
  10. ekf Diagnostics
  11. Abbot
  12. Sekisui Diagnostics
  13. Aldevron
  14. Codexis Inc.

Customization Unleashed: Learn How to Stand Out in a Competitive Landscape! https://www.futuremarketinsights.com/customization-available/rep-gb-17807

Clinical Chemistry Enzymes Market Segmentation:

By Enzyme Type:

  • Acid Phosphatase – ACP
  • Alanine Amino-Transferase – ALT/GPT
  • Alkaline Phosphatase – ALP
  • Aspartate Amino-Transferase – AST/GOT
  • Cholinesterase – CHE
  • Creatine Kinase – CK
  • Creatine Kinase MB – CK-MB
  • Gamma Glutamyltransferase – GGT
  • Glutamate Dehydrogenase – GLDH
  • Hydroxybutyrate Dehydrogenase – HBDH
  • Lactate Dehydrogenase – LDH
  • Lipase – LIP

By Application:

  • Diagnostics Purpose
  • Therapeutic Purpose
  • Analytical purpose

By End User:

  • Hospitals
  • Diagnostics/Pathology Labs
  • Ambulatory Surgical Centers
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Secure Your Competitive Edge! Dive into Exclusive Clinical Chemistry Enzymes Market Analysis with Unbeatable Discounts – Act Now: https://www.futuremarketinsights.com/checkout/17807

Explore Future Market Insights, Inc. Extensive Coverage in Healthcare Market Domain:

Clinical Chemistry Analyzers Market Size: In 2022, the global clinical chemistry analyzers market is likely to hold a value of US$ 13.6 Billion. With a CAGR of 4.8%, the market is projected at US$ 21.7 Billion during the forecast period from 2022 to 2032.

Molecular Biology Enzymes, Kits & Reagents Market Share: The molecular biology enzymes kits reagents market is expected to surpass US$ 48,476.41 Million by 2032 grow at a 15.8% CAGR through 2032

Drug Discovery Enzymes Market Demand: The drug discovery enzymes market is likely to be worth US$ 1,751.3 million by 2033, from its projected value of US$ 932.4 million in 2023. A 6.5% CAGR in the market is predicted during the forecast period.

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Matched content

Editor’s pick

Express Press Release Distribution